Archive | Home Grid

Für das Grid auf der Home Page

2020

Becker S, Fink A, Podlech J, Giese I, Schmiedeke JK, Bukur T, Reddehase MJ, Lemmermann NA. (2020) Positive Role of the MHC Class-I Antigen Presentation Regulator m04/gp34 of Murine Cytomegalovirus in Antiviral Protection by CD8 T Cells.  Front. Cell. Infect. Microbiol. 26 August 2020. DOI Show abstractMurine cytomegalovirus (mCMV) codes for MHC class-I trafficking modulators

Research

TRON conducts collaborative research into immunological mechanisms and therapeutic modulation of the immune system. Specializing in cancer immunology and genomics, our research teams identify and characterize disease-relevant molecular targets, including developing tailored bioinformatical and novel biostatistical approaches. We design and improve cutting-edge technologies for biomarker discovery and biopharmaceutical drug development. In addition to our in-house

PHD PROGRAM

TRON Doctoral Students At TRON we believe in the creative power of gifted and enthusiastic people and in finding and fostering new talents. We offer exceptional opportunities for ambitious scientists to work in a dynamic international research environment to investigate innovative diagnostics and therapies for the treatment of cancer and other severe diseases with high

Careers at TRON

TRON is a rapidly growing biopharmaceutical institute that develops new diagnostics and drugs for the treatment of cancer and other diseases of the immune system. TRON is located in Mainz, Germany, and is part of a strong regional network of science and industry focusing on immunotherapy. Its founders include the state of Rhineland-Palatinate, the Johannes